← Back to Search

Exercise for Prostate Cancer

N/A

Recruiting

Led By Christina C Dieli-Conwright, PhD, MPH

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Over 18 years old; children under the age of 18 will be excluded due to the rarity of the disease

Have been receiving androgen deprivation therapy (ADT) for at least one month with a plan to continue ADT for at least 4 months at the time of recruitment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 4 months

Awards & highlights

Study Summary

This trial will help researchers understand whether a 16-week program of aerobic and resistance exercise can help Black men with prostate cancer who are undergoing androgen deprivation therapy improve their cardiovascular risk factors, physical fitness, and quality of life.

Who is the study for?

This trial is for Black men over 18 with prostate cancer, undergoing androgen deprivation therapy, who exercise less than or equal to 60 minutes per week. They must be able to travel to DFCI for data collection, speak English/Spanish, and have medical clearance to exercise. Excluded are those not on ADT, unable to meet study requirements or with certain medical conditions.Check my eligibility

What is being tested?

The study tests if a 16-week program of culturally tailored aerobic and resistance exercises can improve cardiovascular health in Black prostate cancer patients on ADT compared to usual care without structured exercise. Participants will be randomly placed into one of these two groups.See study design

What are the potential side effects?

While the trial itself does not involve medication that would cause side effects, participants may experience typical physical responses related to new exercise routines such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 years old.

Select...

I have been on hormone therapy for prostate cancer for at least a month and plan to continue.

Select...

I have been diagnosed with prostate cancer, either localized or spread.

Select...

I don't have health issues worsened by exercise like severe bone disease or uncontrolled heart/lung problems.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cardiovascular Diseases

Secondary outcome measures

Cancer treatment symptoms - MDASI

Cardiorespiratory capacity

Fat mass

+12 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Aerobic and resistance exerciseExperimental Treatment1 Intervention

Virtually supervised 16-week aerobic and resistance exercise performed at home via Zoom. The exercises will be performed three times per week for 16 weeks, and virtually supervised by a professional exercise trainer.

Group II: Usual careActive Control1 Intervention

Maintenance of baseline exercise levels for 16 weeks with an offer to perform the same exercise program after 16 weeks.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

PfizerIndustry Sponsor

4,570 Previous Clinical Trials

10,915,949 Total Patients Enrolled

41 Trials studying Prostate Cancer

12,308 Patients Enrolled for Prostate Cancer

Dana-Farber Cancer InstituteLead Sponsor

1,079 Previous Clinical Trials

340,918 Total Patients Enrolled

76 Trials studying Prostate Cancer

16,043 Patients Enrolled for Prostate Cancer

Prostate Cancer FoundationOTHER

47 Previous Clinical Trials

2,718 Total Patients Enrolled

27 Trials studying Prostate Cancer

1,868 Patients Enrolled for Prostate Cancer

Media Library

Aerobic and resistance exercise Clinical Trial Eligibility Overview. Trial Name: NCT05327465 — N/A

Prostate Cancer Research Study Groups: Aerobic and resistance exercise, Usual care

Prostate Cancer Clinical Trial 2023: Aerobic and resistance exercise Highlights & Side Effects. Trial Name: NCT05327465 — N/A

Aerobic and resistance exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05327465 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Approximately how many individuals are participating in this clinical trial?

"That is accurate. According to information hosted on clinicaltrials.gov, this trial has been recruiting participants since August 11th 2022 and was last modified in October 4th 2022. 62 individuals are needed for the study at a single location."

Answered by AI

Is this research endeavor currently recruiting participants?

"According to information readily available on clinicaltrials.gov, this ongoing investigation is actively seeking test subjects, with the initial posting date being August 11th 2022 and the most recent update taking place on October 4th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy

Christina Dieli-Conwright, PhD 2022. "Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05327465.

All > Prostate Cancer Boston